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fever. High consumption of NSAIDs associated with high gastrointestinal side effects. Common complaint 
from patients, which ranging from mild heartburn to the onset of gastrointestinal bleeding, often complicates 
the adequate administration of NSAIDs. Various methods have been developed to reduce the likelihood of 
gastroenteropathy complication. Early diagnosis, appropriate prompt treatment, as well as adequate monitoring 
will reduce morbidity and mortality from complications due to NSAIDs. This paper will discuss the diagnosis 
and management of gastro-enteropathy NSAID through approaching the underlying pathophysiology.
Keywords:????????????????????????????????????????????????????????????????????????
???????
?????????????????????????????????????????????? ???????????????????????????????????????????? ?????????
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tinggi pulalah efek samping gastrointestinal yang dilaporkan terkait dengan penggunaannya. Keluhan umum 
yang dirasakan pasien mulai dari nyeri ulu hati ringan hingga timbulnya perdarahan saluran cerna kerap 
menjadi penyulit dalam pemberian OAINS secara adekuat. Berbagai cara telah dikembangkan guna mengurangi 
kemungkinan terjadinya komplikasi gastro-enteropati. Penegakkan diagnosis secara dini, penanganan awal yang 
tepat, serta pemantauan yang adekuat akan menurunkan angka morbiditas dan mortalitas akibat komplikasi 
akibat OAINS. Pada makalah ini akan dibahas mengenai diagnosis dan tatalaksana gastro-enteropati OAINS 
???????????????????????????????????????????????????
Kata kunci:??????????????????????????????????????????????????????????????????????
????????????
?????????????????????????????????????????????????
??????????????????????????????????????????????????????
fever.??? High consumption of NSAIDs associated with 
high gastrointestinal side effects. Common complaint 
????????????????????? ???????? ?????????? ??????????
??? ????????????????? ?????????? ?????? ???????????? ????
adequate administration of NSAIDs.?? ??????????
incidence of NSAID-induced gastropathy is increasing 
along with the high consumption of NSAIDs. In the 
??????? ??????? ???????????? ?????????????? ???? ???
???????????????????????????????????????????????????
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??????????????????? ??????????????????????????????
??????????? ?????????? ????? ????????? ??? ???????????
gastrointestinal complications due to NSAID ranging 
????????????????
These drugs are commonly used in patients with 
autoimmune or elderly patients with joint pain in 
????????????????????????????????????????????????????
????????????? ?????????????? ??????????????? ????????
often use NSAIDs wheter as single theraphy or in 
combination with other anti platelet aggregation drugs 
to minimize the thrombus formation.???????????????????
gastrointestinal side effects become a problem which 
led to inappropriate drug discontinuation. Along with 
???? ???????????? ??????????? ???????? ??? ???????? ????
gastrointestinal side effects associated with NSAIDs 
consumption is increasing. Prevention efforts began 
with the early diagnosis of patients who have high-
risk to have gastrointestinal bleeding due to NSAIDs 
consumption to the administration of mucoprotective 
drugs and gastric acid–suppressive drugs. 
??????????? ????????????????? ??????? ??????????
is based on its ability to inhibit the biosynthesis of 
prostaglandins from arachidonic acid on the molecular 
??????? ??? ???????? ???? ??????????????? ????????????
????????? ??? ???? ????????????????????????????????
??????????????????????????????????????????????????
activation is protective in maintaining the integrity of the 
???????????????????????????????????????????????????????
?????? ????? ??????????????????? ????????????????????
process which occurs. Inhibition to the gastroprotective 
prostaglandins will cause a variety of gastrointestinal 
side effects associated with the use of NSAIDs.????These 
???????????????????????????????????????????????????????
????????????? ???????? ??????? ????? ?????????????????
increasing the risk of gastrointestinal disruption.???  This 
paper will discuss the diagnosis and management of 
gastropathy and enteropathy due to NSAID as well as 
prevention which can be done to reduce the morbidity 
and mortality due to NSAIDs consumption.
????????????
Gastro-enteropathy is a medical term used to describe 
abnormalities in gastric mucosa and the small intestine 
????????????????????????????????????????????????????
???????????????????????????????????????????????????
induced gastro-enteropathy is a disorder of the gastric 
mucosa and intestine due to consumption of NSAIDs. 
The incidence of NSAID-induced gastropathy is 
relatively high due to widespread use.
??? ?????????????????? ???????????? ??????????????
????????????????????? ?????????????????????????????
????????????????????????????????????????????????????
or perforation in gastrointestinal tract. The incidence of 
?????????????????????????????? ?????????? ????????? ???????
??????????????????????????????????????????????????????
year.??Gastrointestinal tract bleeding is the most often 
manifestation of bleeding which occurs as the result of 
antiplatelet use. Studies show the use of low-dose aspirin 
???????? ????????????????????????????????????????????????
The incidence rate of upper gastrointestinal bleeding due 
??? ?????????????? ???? ??? ???????? ???? ??????????????
???????????????????????????? ??????????????????????????????
???????????????? In Indonesia gastrointestinal bleeding 
due to NSAID gastropathy was ranked second after the 
rupture of esophageal varices. NSAID gastropathy itself 
was ranked second after gastropathy due to Helicobacter 
pylori infection.?????????????????????????????????????
at Table 1.
????????????????????????????????
????? ???????????????????? ?????????????
Salicylates Derivatives of 
2-hydroxybenzoic 
acid (salicylic acid)
????????????????????????
salsalate
Propionic acid 
derivatives or 
“profens”
Derivatives of 
arylacetic acids
Ibuprofen, 
dexibuprofen, 
ketoprofen, 
dexketoprofen, 
naproxen, fenoprofen, 
?????????????
oxaprozin, and 
loxoprofen
Acetic acid 
derivatives
Derivatives of acetic 
acids
Indomethacin, 
diclofenac, 
nabumetone, tolmetin, 
sulindac, etodolac, 
and ketorolac
Enolic acid 
derivatives or 
fenamates
Derivatives 
of 4-hydroxy 
benzothiazine 
heterocycle
Piroxicam, isoxicam, 
meloxicam, 
tenoxicam, droxicam, 
and lornoxicam
Fenamic acid 
derivatives or 
fenamates
Derivatives of 
anthranilic acid
Mefenamic, acid, 
????????????????
tolfenamic acid, and 
meclofenamic acid
Phenylpyrazolones Derivatives 
of 1-aryl-3,5-
pyrazolidinedione
Phenylbutazone, 
oxyphenbutazone
COX-2 selective 
inhibitors
Diaryl-5-membered 
heterocycles
Celecoxib, rofecoxib, 
and valdecoxib
Anilides and 
sulphoanilides
Acetamides of 
aniline with or 
without a 4-hydroxy 
or 4-alkoxy group
A c e t a m i n o p h e n , 
phenacetin, and 
nimesulide
?????????????????????????????
Mechanism of gastric and proximal duodenal 
??????????????????? ?????????? ??? ???????????????
while the pathogenesis of small intestine damage 
due to NSAIDs is not known clearly. The occurrence 
of NSAID enteropathy involves more complex 
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??????????????????????????????????????????????????????
it also involve intestinal bacteria and the NSAIDs 
enterohepatic recirculation.4 Several studies have found 
that the use of gastric acid suppresive drugs does not 
have satisfactory results in lowering the incidence of 
NSAID enteropathy.
NSAIDs consisting of carboxylic acid or enol groups 
?????? ??????? ??? ???? ??????????? ??????? ????????????
Prostaglandins which synthesized from arachidonic acid 
???????????????? ????????????????????????????????????????
became the main target of NSAIDs (Figure 1).
???????????????????????????????????????
The main pathophysiology of NSAID-induced 
gastrointestinal damage consists of three main 
?????????????????? ???? ??????????? ??? ?????? ????
??????????????????????????? ??????????????????????????
production of the main pathophysiology of NSAID-
induced gastrointestinal damage consists of three main 
???????????? ??????? ???? ??????????? ????????? ????
??????????????????????????? ??????????????????????????
??????????????????????????????????????????????????
?????????????????????????????????? ???????????????
???? ????????? ???????? ???? ?????????? ?????? ????
????????????? ???????? ??? ?? ????????????? ????????
?????? ????????? ??? ??????????????? ????????????????
??????????????????????????????????????? ?????????? ?????
??????????????????????????????????? ????? ?????????
??? ???? ????????????? ???? ??????? ????????????????????
pathway inhibits the production of prostaglandins 
??????????? ??? ?????????? ????? ??? ???????? ????????????
???????????????????????? ?????????????????????????????
??????????????? ???????? ??? ?????????? ???? ?????????? ???
mucus and bicarbonate. The inhibition of prostaglandin 
?????? ???????? ??????????? ?????????????????? ???????
which resulting in the gastric environment becomes 
more vulnerable to endogenous factors such as bile 
????????????????????????
Suppression of mucosal prostaglandin will cause 
mucosal damage. This is related to the role of prostaglandins 
in improving many components of mucosal defenses such 
as bicarbonate and mucus secretion by epithelial cells 
which caused cell resistance to acid and pepsin as well as 
the promotion of epithelial damage repair.4 Prostaglandins 
???????????????????????????????????????????????????
??????????????? ??? ?????? ??????????????? ???? ???????
???????????????????? ???????????????????????????? ??????
when the damage epithelial barrier in occurred. Increased 
??????????????? ????? ???????????????? ???? ???????????
diffuses back and in clean the toxic substances which 
enter into the sub epithelial.4 
???????????????????????????????????????????????
has developed with combination with NO or hydrogen 
??????????????? ????? ???? ??? ??????? ?????????? ??? ????
??????????? ????????? ??? ???? ????????? ?????????????
leading to damage of the gastric and intestine mucosal.
?????????????????????????????????????????????????????
????????????? ???????? ??????????? ???????? ????
directly damage the gastric mucosa and causes 
???????????????????????????????????????????????????????
???????????????????????????????????????????????????????
?????? ???? ??? ???? ????????????? ??? ???????????????
which then led to changes in permeability of the 
mucosa as well as induces apoptosis and necrosis of 
mucosal cells.??Inhibition of prostaglandin synthesis 
by NSAIDs causes stimulation of lipo-oxygenase 
pathway activation and increases leukotrienes 
production. Leukotrienes cause inflammation and 
tissue ischemia which led to injury in gastric mucosa. 
?????????? ??????????? ??? ?????????????????????????
such as TNF also occurs. This will increase the risk of 
microcirculation occlusion which will cause a decrease 
????????????????????????? ???????? ????? ???????????????
radicals will bind with fatty acids which then cause 
lipid peroxidation and tissue damage.?
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?????????????????????????????????????
The ability of NSAIDs to cause damage to the 
gastrointestinal mucosa associated with its ability 
to inhibit the synthesis of prostaglandin. The use of 
???????????????????????????????? ???????? ????? ????
reduce the risk of gastrointestinal disorders. The use 
??? ?????????????????????????????????????????????????
(PPI) effectively shows that acid plays major role in 
the pathogenesis of gastroduodenal mucosal damage. 
?????????????? ????????? ????????????????????????????
the acidic pH will penetrate the mucosa causing further 
damage and mucosal bleeding. This is due to the loss of 
the platelet aggregation ability at a pH of less than 4.4
??????????????????????????????????????
Pathogenesis of small intestine is damage different 
than gastroduodenal damage. A longer time is 
needed in order to trigger the small intestine mucosal 
???????? ????????? ??? ???????????????? ???????? ???
?????????????????????????????????????????????????????
damage similar to the pathogenesis of gastric mucosal 
??????????????????????????????????????????????????
the supressed synthesis of prostaglandins does not 
necessarily lead to ulcers formation and bleeding. 
Important pattern which connected the use of 
NSAIDs with small intestinal mucosal damage is the 
absorption of secreted material in the ileum back into 
the duodenum through the enterohepatic circulation. 
????????????4 A mixture of bile components and NSAIDs 
can directly damage the intestinal mucosa through the 
uncoupling oxidative phosphorylation mechanism. 
??????????????? ???????????? ???? ???? ?????????????????
????????????????????????????????????????????????????
gram-negative bacteria is important in causing ulcers 
in patients with NSAIDs enteropathy.4
????????????????????????????????????????????
????? ??????? ?? ????? ??????? ??????????
???????? ???????? ????? ?????????? ????? ???????? ????
NSAIDs gastrointestinal complications. Studies show 
??????????????????????????????????????????????????????
gastrointestinal side effects than patients with age 
????????????????????????????????????????????????????
????????????????????????????????????????????????????
?????????????????????????????????????????????????????
?????????????????????????????????????????????????
History of complicated or non-complicated ulcers 
is the most important risk factor for the occurrence of 
??????????????????? ??????????????????????????????????
????????????????????????????????????????????????????????
The risk become greater if complications occur in the 
history of previous ulcers.??Age is the second risk factor 
which plays role. Studies clearly showed an increased 
???????? ?????????????????????????????????????????????
???????????????????????????????????????????????????????
?????????????????????????????????????????????????????
of previous ulcer.?
Some studies have found that short-term use 
?????????? ?????? ??????????????? ???? ??????? ????? ???
peptic ulcer. Although that risk will be reduced after 
a few months NSAID usage but it will not disappear 
??? ???? ?????????? ????? ??? ?? ??????? ??????????? ?????
rheumatoid arthritis patients showed that patients 
with cardiovascular disease have the highest risk of 
upper gastrointestinal complications with the usage of 
??????????? ???????? ???????? ????????????????????????
??????????????????????????????????????????????????????
?????????????????????????????????????????????????????
Another study showed that the risk of gastrointestinal 
complications is lower in the use of NSAIDs such as 
??????????? ????????????????????? ???? ????????? ????
??????????????????????????????????????????????????
ketorolac. It is suspected due to low doses in daily 
???? ???? ??????????????????????????? ???? ?????????
??????????????????????????????????? ?????????????????
Increased risk of gastrointestinal complications in the 
???? ??? ?????????? ??????????? ?????????????? ??????????
because longer half-life and therefore that longer 
mucosal exposure. A SOS study showed aceclofenac 
????????????????????????????????? ???????????????????????
??? ????????????????? ????? ???????????????????? ?????????
??????????????????????????????????????????????????????
?????????????? ??????????? ?????????? ??????????? ????
ketorolac high risk (RR > 4).?
The role of H. pylori infection as a risk factor 
of gastrointestinal bleeding in patients with NSAID 
therapy remains controversial. Most of the studies 
showed an increased risk of NSAID gastropathy 
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complications with H. pylori infection. One study 
??????? ??? ?????????? ????? ??? ????? ??? ???? ??????????
of NSAIDs with H. pylori infection and it is higher 
????????? ????????? ???????? ?????? ???? ?? ???????
Another study indicated that presence of H. pylori 
infection with the use of NSAIDs increases the risk 
of gastrointestinal bleeding of 6.1 times.?
Eradication of H. pylori infection also showed a 
decreased risk of gastropathy OANS. But the role of 
H. pylori eradication in patients with NSAID therapy 
??????????????????????? ????? ??????????????????????????
of H. pylori may be as effective for lowering the 
risk of peptic ulcers either as primary or secondary 
prophylaxis at the beginning of NSAID use. But in 
???? ?????????? ???? ??????????? ???????????? ???? ????
??????? ??????????? ????????????????? ?????????? ????
risk of NSAIDs gastrointestinal complications which 
is highest in the early months of use. In patients who 
did not experience the initial effects presumed to be 
able to tolerate these drugs without concerning their 
H. pylori?????????????????????????????????????????????
?????????????????????????????????????????????????????????
aspirin. This is presumably because low-dose aspirin 
has an lower ulserogenic effect than NSAIDs.?
The use of NSAIDs with gastrotoxic drugs also 
increase the risk of NSAID gastropathy. Antiplatelet 
use as mentioned above has a risk gastrointestinal 
complications. Antiplatelet without the use of NSAIDs 
???????????????????????????????????????????? ?????????
???????????????????????????????????????????????????????
ibuprofen and naproxen are considered to have the 
????? ???????????????????????????? ???????????????????
both still can affect the antiplatelet effects which can 
increase the cardiovaskular risk.????
The relationship between use of corticosteroids 
alone and risk of gastrointestinal bleeding is still 
???????????????????????????????????????????????????????????
of bleeding when combined with NSAIDs.??? Treatment 
of NSAID gastropathy requires an assessment of the 
????????????????????????????? ?????????????????????????
which used today is by the American College of 
Gastroenterology ???????? 
?????? ??? ????? ??????? ?????????? ??? ????????? ????????
????????????????
???? ?????????????????????
High risk History of previous complicated ulcers
> 2 risk factors
Intermediate risk age > 65 years old  
High dose NSAIDs use
History of previous non-complicated ulcers
Use with aspirin, corticosteroids, or anticoagulants
Low risk No risk factor
Independent risk 
factor
H pylori infection
?????????????????????????????????????
Diagnosis of the occurrence of NSAID gastro-
???????????????????????????????????????????????????????
of complaints and signs which found by physical 
examination. The severity of mucosal erosions or 
ulcers that occur will determine the severity of the 
patient's clinical manifestations.
Forms of bleeding which can be encountered 
ranging from occult bleeding to life-threatening 
hematemesis melena. The occurred damage could be 
??????????????????????????????????????????????????????????
The most encountered clinical manifestation is vague 
gastrointestinal bleeding. Bleeding associated with 
????????????? ???????? ??????? ????? ?????????????
??????????????????????????????????????????????????? A 
typical sign of NSAID gastropathy was the discovery 
????????????????????????????????????? ??????????????????
stricture.?
Diagnosis via endoscopic examination of the upper 
gastrointestinal tract and radiographic examination 
?????? ??????? ?????? ??? ????? ??? ?????????????????? 
?????? ???? ??????????? ????????????? ???????? ???? ???
viewed directly and followed by biopsy for additional 
????????????????????????????????????????????????????
done to see the small intestinal mucosal involvement. 
????????????????????? ???????????? ?????? ??? ???????
???????????????????????????????? ???????????????????????
also be done as one of non-invasive modalities.???
???????? ?? ??? ???????? ?? ????? ??????
???????????
??????????
Prevention of NSAID gastro-enteropathy starts 
?????????????????????????????????????????????????????
?????????????????????????????????????????????????????
???????????????????????????????????????????????????????
indications and duration of NSAIDs administration. 
Several approaches are used in the prevention 
??? ?????? ????????????? ????? ??? ???????????????
?????????????????????????????????? ?????? ???? ???
???????????????????????????????????Helicobacter pylori 
eradication.???? Substitution of ASA with clopidogrel in 
???????????????????????????????????????????????????
administrated carefully because omeprazole can inhibit 
???? ??????? ??? ??????????????????????????? ????????
clopidogrel metabolism into their active metabolites.???
Prevention methods of mucosal damage and 
NSAID-induced peptic ulcer disease are by cotreatment 
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?????????????????????????????????????????????????????
??????????????????????????????????????????????????
Enteric coated NSAID administration give no 
???????????????????????????????????????????????????????
ulcer.
????????????????? ?????
Acid increases the risk of mucosal injury by 
??????? ???? ??????????? ?????????????? ?????????
antagonists and proton pump inhibitors (PPIs) are 
most commonly used suppression agents. PPI not only 
reduce acid but also maintain the gastric pH and has a 
role in the free radical binding.6
??????????????????????????????????????????????????
preventing NSAID gastropathy particularly peptic 
???????? ???????????????????????????????????????????????
???????????????????????????????????????????????????????
?????????????????????????????????????????????????????
???????????????????????????????????? ??? ???? ??????????
????????????????????????????????????????????????????????
antagonists which about twice a day use is considered 
effective in preventing the occurrence of duodenal 
?????????????????????????????????????????????????????????
?????????? ?????????????? ??? ???????????????????????
antagonists may reduce the incidence of gastric and 
duodenal ulceration. 
????????? ??? ????????? ???????????? ???? ?????
????????????? ????? ?????????? ????? ???????? ??? ?????????
???????????????????? ????????????????????????????????????
????????????????????????????????????????????????????????
???? ??????????? ??? ?????? ??????????????? ???????????
??? ????????? ???????????? ???? ???? ???????????? ????
the prevention and treatment of NSAID gastropathy 
especially in asimptomatic cases.???
PPIs are effective drugs in the acid suppression 
and prevent the incidence of peptic ulcers in patients 
with NSAID therapy. PPIs showed minimal side 
???????? ?????????? ???? ??? ????? ??? ???? ????? ?????? ???
????????????????????????????????????????????????????
(omeprazole) significantly decrease the incidence 
rate of ulcers associated with NSAIDs. Another study 
??????? ?????????????????????? ?????? ?????????????
per day is more effective than the use of misoprostol 
to prevent gastric ulcers in patients on NSAID therapy 
with negative H. pylori????????????????????? ?????????
that PPIs may reduce the risk of NSAID gastropathy 
?????? ?????????? ??? ????? ??????? ??????? ?????? ????? ?????
???????????????????????????????????????????????????? ??
?????????????????????????????????????????????????????
the treatment of mucosal injury in the distal part of the 
colon as well as NSAID colonopathy.?????
?????????????? ??????
Prostaglandin analogs are used to replace 
prostaglandin formation which inhibited by NSAIDs. 
Prostagladin in gastrointesinal mucosa works to increase 
????????????????????????????????????????? ?????????????
???????????????????????????????????????? Misoprostol 
??? ????????? ????????? ????? ?????????????? ????????
was found able to decrease gastrointestinal ulceration 
induced by NSAIDs. Misoprostol is a E1 synthetic 
prostaglandin analog used to replace cytoprotector 
prostaglandin which decreased by NSAIDs. In the 
????????????????????????????????????????????????????????
and misoprostol is effective for arthritis and decrease 
the incidence of NSAID gastropathy.
Studies have showed that misoprostol therapy of low-
?????????? ????????????????????????????????????????????
in preventing duodenal ulcer. It was considered because 
of minimal incidence of H. pylori in the study. Another 
study showed there was no significant difference 
between PPI and misoprostol in preventing endoscopic 
ulcers. MUCOSA study showed that standard dose 
??????????????????????? ??? ??????????? ?????????? ???
preventing NSAID gastropathy ulcer (prevention 
??? ?????????????? ??? ??? ??? ????????Misoprostol also 
have adverse effects on the gastrointestinal tract. The 
????? ????????? ??????????? ????????????? ????????????? ???
????? ???? ?????? ?????????? ?????? ???????? ????????????
bleeding. These limitations of misoprostol cause the 
patient compliance becomes vulnerable. Several studies 
showed that misoprostol is more inferior than PPIs in the 
treatment of gastric and duodenal ulcers associated with 
NSAIDs. Studies showed low doses of misoprostol have 
???????????????????????????????????????????????????????
?????????????????????????????????????????????????????
fail to show a reduction in the risk of dypepsia and other 
gastrointestinal side effects.?????
??????????
Rebamipide is gastro-enteroprotective drug which 
working mechanisms are to stimulating endogenous 
?????????????? ??????????? ???????????? ????? ?????????
and reducing pro-inflammatory cytokines in the 
gastrointestinal tract. Several studies showed that 
rebamipide effectively prevents NSAID-induced 
gastropathy including aspirin. STORM Study 
showed that rebamipide as effective as misoprostol 
in preventing NSAID gastropathy with a better 
??????? ??????????????????? ????? ?????? ?? ????? ??? ????
prevention of lesions in the small intestine mucosa. 
????????????? ??????????????????????????????????????
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???????????????????????????????? ????????????????? ????
???????????????????????????????????????????????????????
combination with PPIs proved to increase the cure rate 
and reduce the recurrence rate.?
????????????????????
Sucralfate is aluminum salts based mucoprotector 
which form complexes adherent to duodenal ulcer. 
??????????????????????????????????????????????????????
duodenal ulcer which only effective if NSAIDs therapy 
is stopped. Sucralfate is not effective in the prevention 
of gastric ulcers associated with NSAIDs.?
??????????????????????????
Research on low gastrotoxic NSAIDs led to the 
???????????? ??? ?????? ???????????? ??? ???? ??????
??????????????? ???????????????????????????????????
???????????????????????????????????????????????????
????????????? ??????????? ?????? ??????????? ????
?????????? ????????? ????????????????? ?????? ??? ??????
???????????????????????????????????????? ??????????
but has no gastrointestinal effects.
Examples of this class of drugs are rofecoxib and 
??????????? ?????????????????????????????????????????
????? ?????????? ????????? ?????????? ??? ?????????? ????
????????????? ?????????? ??????????????????????? ???
?????????????????????????????????????????????????????
????????????? ?????????????????????????? ?????????????
??????????????? ????????????????????????????????????
?????????????????????????????????????????????????
?????????????????????????????????????????????????????
??????????????????????????????????????????? ????????
???????????????????????????????????????????????????
????? ?????? ??????????????? ?????? ?????????? ??????
????????????????????????????????????????????????????
to non- selective NSAIDs.????
?????????????????????????????????????????????????
aspirin has a smaller risk of bleeding compared with 
???????????? ?? ?????????????????????????????? ? ?????
???? ??? ??????????? ???????????????????????? ?? ?????
inhibitor and anticoagulant also has lower risk of bleeding 
than conventional NSAIDs. The latest recommendation 
?????? ??????????? ?????????? ??? ????????? ??????????
therapy in patients on therapy antikoagulan.????
??????????????????????????????? ?????????????????
??????????????????????????????????????????? ??????
???????????????????????????????? ?? ?????? ?????? ???? ???
???????????????????????????????????????????????????????
??????????????????????????????????????????? ?????????????
?????????????????????????????????????????????? ?????
study showed that celexocib administration have less 
incidence compared to conventional NSAIDs within 
??????????????????????? ??? ??????? ??? ??????? ???????????
difference after one year use.?????
????????? ?????? ?????????? ??????? ??? ???????
gastrointestinal toxicity but it has a corelation with 
the risk of cardiovascular events such as myocardial 
??????????????????????????? ??????????????????????? ???
?? ?????????? ??????????? ??? ????????????????? ?????????
aspirin showed unsatisfactory results.
????????????????????
?????????????????????????????????????????????????
production of leukotrienes. Leukotriene is a potent 
??????????????????????????????????????????????????
???????????????????? ????????????? ???????????????????
??? ????????? ????? ?????????????? ??????????????????
??????????????? ???????????????????? ?????????????????
pharmacodynamic effect. Licofelone expected to have 
???????????????????????????????????????????????????????
minimal gastrointestinal effects. While development 
of Benoxaprofen has discontinued because its severe 
?????????????????????????????????????
???????????
Some studies found that human recombinant 
lactoferrin can reduce gastric ulceration and 
gastrointestinal bleeding associated with NSAIDs 
therapy. The latest report also shows the C-lobe of 
lactoferrin are able to bind to the drug that binds to 
????????????????????????????????????????????????????
??????????????????????????????????????????????????? ???
obtained that the effectiveness of lactoferrin is same 
??????????
???????????????
New types of NSAIDs have been developed such as 
?????????????? ??????????? ?????????????????????
???????????????????????????????????????????????????????
stimulate mucosal integrity. The interaction of NSAIDs 
????? ????? ??????????????? ????????????????????????????
the inhibition of prostaglandin production.???
???????
????????????????????????? ????????????????????????
are by discontinuing NSAID or replacing it with an 
???????????????????????????????????????????????????????
???????????????????????????????????????????????????
??????? ???? ?????????? ???? ???? ?????????? ??????? ???
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????????????????????????????????????????????????????????
short-term and long-term therapy.6
Short-term therapy of peptic ulcers and 
gastrointestinal bleeding due to NSAID gastropathy 
are no different from therapy for other causes which 
?????????? ???????? ??????????????? ???????????????? ????
????????????????????????????????????????????????????????
therapy for NSAIDs should be given. In patients who 
?????????? ?????????????????????????????????????????
?????????? ??????????????????????? ????????????????????
???????????? ???? ??????????????????????????????????????
decreased significantly when patients keep taking 
???????? ????????????????????????????????????????????
????????? ?????????? ????????????????? ???????????? ????
misoprostol in healing ulcers in patients who continuing 
??????? ?????????????????????? ???? ????????????????
PPIs and NSAIDs themselves also have the same risk of 
???????????????????????????????????????? ????????????????
?????????????????????????????????????????? ??????
??????????????????????????????????????? ??????????????????
???????????????????????????????? ????????? ????????????
????????????????????????????????????????????????????????????
This also applies to NSAID gastropathy with H. pylori 
patients.6 Prevention scheme in the treatment of NSAID 
gastropathy can be seen in Figure 4.?
??????????
??????????? ?????????????????????????????? ?????
lead to high incidence of complications associated with 
patient gastrointestinal complaints. Complications can 
be mild or severe. Early diagnosis for assessing the 
severity of mucosal damage which occurs is based on 
???????????????????????????????? ??????????????????????
endoscopy is still the gold standard in to assess mucosal 
damage which occurs.
The frequent NSAID-induced gastrointestinal side 
effects complicate the administration of the drugs 
according the appropriate dose and indication. Assessment 
??????? ????????????????? ?????????????????????????? ?? ???????
prevention methods are needed to be done in order to 
decrease the morbidity and mortality of gastrointestinal 
complications due to NSAIDs.
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Low cardiovaskular risk Conventional NSAID Convensional NSAID + PPI/misoprostol Alternative theraphy or 
COX-2 inhibitor + PPI/
misoprostol
High cardiovaskular risk
(consider aspirin)
Convensional NSAID + PPI/misoprostol 
or alternative theraphy
Convensional NSAID + PPI/misoprostol 
or alternative theraphy
Alternative theraphy Avoid 
NSAID or COX-2 inhibitor
*Low cardiovaskular risk: No need of low dose aspirin or clopidogrel; High cardiovaskular risk: Need of low dose aspirin or clopidogrel
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